Table 2.
Study ID | Journal | Study Design | Center/Country | Enrolled Criteria (n) | Age | NMB Reversal Agent |
---|---|---|---|---|---|---|
Adams et al., 2020 [7] | Anaesthesia | Two centers retrospective study | Pittsburgh Medical Center, Memorial Sloan Kettering Cancer Center, USA | End-stage renal disease which is mandatory for renal replacement therapy (158) | ≥18 | sugammadex |
Paredes et al., 2020 [16] | Canadian Journal of Anaesthesia | Historical cohort study, three-distinct geographic locations | Scottsdale, AZ, Jacksonville, FL, Rochester, MN, USA | eGFR value < 15 mL min−1 (219) | ≥18 | sugammadex |
Ono et al., 2018 [6] | Journal of Anesthesia Clinical Reports | Retrospective study | Aichi Medical University, Nagakute, Japan | Diagnosed severe with renal failure and underwent renal transplantation (99) | not mentioned | sugammadex |
eGFR = estimated glomerular filtration ratio. NMB = neuromuscular blockade.